2197

COM:CLOVERBIOPHARMA

Clover Biopharmaceuticals

  • Stock

Last Close

0.29

22/11 07:42

Market Cap

415.27M

Beta: -

Volume Today

981K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Apr '21
Jun '21
Sep '21
Dec '21
Mar '22
Jun '22
Sep '22
Dec '22
Mar '23
Jun '23
Sep '23
Dec '23
Mar '24
Jun '24
asset turnover
0.00
-
0.00
-
0.00
0%
0.01
22,133.58%
0.01
0%
-0.00
130.28%
-0.00
0%
cash conversion cycle
13.68K
-
544.11
-
544.11
0%
281.28
48.30%
281.28
0%
587.28K
208,684.85%
587.28K
0%
cash per share
2.10
-
1.44
-
1.01
-
1.04
2.46%
0.60
41.87%
0.60
0%
0.39
34.94%
0.39
0%
company equity multiplier
-1.36
-
4.38
-
4.38
0%
29.52
573.27%
29.52
0%
-7.03
123.80%
-7.03
0%
107.84
1,634.69%
107.84
0%
-2.87
102.66%
-2.87
0%
-2.16
24.74%
-2.16
0%
days of inventory outstanding
2.09K
-
37.16K
-
888.42
-
170.13
-
170.13
0%
263.83
55.08%
263.83
0%
793.75K
300,752.44%
793.75K
0%
days of payables outstanding
1.60K
-
23.48K
-
319.31
-
32.94
-
32.94
0%
93.81
184.77%
93.81
0%
206.47K
219,985.47%
206.47K
0%
days of sales outstanding
0.00
-
406.93
-
406.93
0%
111.26
72.66%
111.26
0%
-0.07
100.06%
-0.07
0%
dividend yield
ebit per revenue
-74.49
-
-6.85K
-
-6.85K
0%
-21.77
99.68%
-21.77
0%
15.58
171.55%
15.58
0%
ebt per ebit
1.73
-
3.18
83.31%
1.02
-
1.05
-
-0.37
-
-0.37
0%
0.93
351.53%
0.93
0%
0.60
34.95%
0.60
0%
effective tax rate
0.00
-
0.00
-
0.00
0%
enterprise value multiple
3.70
-
-7.02
-
-0.56
-
-0.58
-
-0.47
20.11%
-1.14
145.22%
-0.59
48.23%
-2.78
369.78%
-1.71
38.40%
fixed asset turnover
0.03
-
0.00
-
0.00
0%
0.12
20,409.71%
0.12
0%
-0.03
128.71%
-0.03
0%
free cash flow per share
-0.28
-
-0.52
-
-0.17
-
-0.17
0%
-0.07
-
-0.07
0%
gross profit margin
0.50
-
-4.81K
-
-4.81K
0%
-11.19
99.77%
-11.19
0%
1.02
109.07%
1.02
0%
interest coverage
-66.25
-
inventory turnover
0.04
-
0.00
-
0.10
-
0.53
-
0.53
0%
0.34
35.52%
0.34
0%
0.00
99.97%
0.00
0%
long term debt to capitalization
-0.01
-
0.04
-
0.04
0%
0.23
539.35%
0.23
0%
-0.06
-
0.44
-
-0.01
102.48%
-0.01
0%
net income per ebt
1
-
1
0%
1
-
1
-
1
-
1
0%
1
0%
1
0%
1
0%
1
0%
net profit margin
-76.33
-
2.53K
-
2.53K
0%
-20.24
100.80%
-20.24
0%
9.42
146.54%
9.42
0%
operating cash flow per share
-0.26
-
-0.51
-
-0.17
-
-0.17
0%
-0.07
-
-0.07
0%
operating cycle
37.16K
-
577.05
-
577.05
0%
375.10
35.00%
375.10
0%
793.75K
211,511.16%
793.75K
0%
operating profit margin
-74.49
-
-6.85K
-
-6.85K
0%
-21.77
99.68%
-21.77
0%
15.58
171.55%
15.58
0%
payables turnover
0.06
-
0.00
-
0.28
-
2.73
-
2.73
0%
0.96
64.88%
0.96
0%
0.00
99.95%
0.00
0%
pretax profit margin
-76.33
-
2.53K
-
2.53K
0%
-20.24
100.80%
-20.24
0%
9.42
146.54%
9.42
0%
price fair value
34.22
-
-2.93
-
62.06
-
42.52
31.49%
-1.22
102.87%
-0.91
25.49%
-0.53
41.99%
-0.44
16.91%
receivables turnover
7.44M
-
0.22
-
0.22
0%
0.81
265.73%
0.81
0%
-1.26K
156,178.90%
-1.26K
0%
return on assets
-0.44
-
-0.11
-
-0.14
-
0.11
-
0.11
0%
-0.19
277.72%
-0.19
0%
-0.03
85.91%
-0.03
0%
return on capital employed
-0.23
-
-0.21
-
-0.34
-
-1.24
-
-1.24
0%
2.42
295.49%
2.42
0%
0.29
88.21%
0.29
0%
return on equity
-1.93
-
-3.22
-
0.98
-
11.39
-
11.39
0%
0.54
95.27%
0.54
0%
0.06
89.39%
0.06
0%
total debt to capitalization
-0.02
-
0.04
-
0.05
43.81%
0.23
344.58%
0.31
33.14%
-1.13
-
0.94
-
-0.76
180.52%
-0.76
0%
-0.34
54.66%
-0.34
0%

All numbers in (except ratios and percentages)